Photo by Pharmacy Images on Unsplash
Health Insurance to Cover Long Covid Drugs
From now on, statutory health insurances in Germany will cover the costs of four specific medications prescribed to Long Covid patients. Previously, patients often had to pay for these prescription drugs themselves. This change results from a decision by the Gemeinsame Bundesausschuss (G-BA), the joint federal committee responsible for determining statutory health insurance coverage in Germany, which has approved these medications for off-label use to alleviate Long Covid symptoms [Source 1].
Long Covid describes conditions where symptoms persist or reappear at least four weeks after a confirmed coronavirus infection, with no other explanation. Symptoms often include fatigue, cognitive impairment, and pain, significantly impacting patient quality of life [Source 1].
Four Medications Approved for Reimbursement
The approved drugs are primarily approved for other diseases but have shown promise in treating Long Covid symptoms. These include Agomelatin, an antidepressant aimed at combating severe fatigue (also known as post-infectious Fatigue Syndrome or ME/CFS), and Metformin, typically a diabetes medication which may help prevent Long Covid in overweight individuals [Source 3]. The other two medicines, not always detailed explicitly in all sources, also serve to address symptoms such as exhaustion and cognitive challenges [Source 4].
This approval by the G-BA is still pending formal ratification by the Federal Ministry of Health but is expected to proceed smoothly. Experts emphasize that there are currently no drugs specifically approved for Long Covid treatment, so this off-label use represents an unprecedented but critical step to improving care for approximately one million people estimated to suffer from Long Covid in Germany [Source 4].
Implications for Expats and Foreign Residents
This development is particularly relevant for expats, international students, and foreign workers in Germany who suffer from Long Covid. Previously, many patients had to bear the full cost of medications themselves, which could be financially burdensome. With statutory health insurance now covering these treatments, those insured under the public system will benefit from reduced out-of-pocket expenses and easier access to medical therapies [Source 1].
However, as these drugs are prescribed off-label for Long Covid, patients should consult their healthcare providers to understand eligibility and treatment protocols. Expats should verify their insurance coverage status, as private insurance policies may differ. This change provides a pathway for better symptom management, potentially reducing the impact on daily life and work productivity.
Next Steps and Further Information
Physicians in Germany can now prescribe these medications on a health insurance prescription for Long Covid patients, marking an important milestone in managing post-Covid health challenges. The decision highlights growing recognition of Long Covid’s severity and the healthcare system’s response to support affected patients [Source 8].
For the latest official updates and guidance on Long Covid treatments covered by health insurance, patients and doctors are advised to monitor communications from the G-BA and the Federal Ministry of Health.
More details can be found in the original Tagesschau coverage: Long Covid: Krankenkassen übernehmen bald einzelne Medikamente [Source 1].
